Healthcare ETFs to Buy as Eli Lily Steps Into Vaccine Market With $4B Bet
Pharma giant Eli Lily LLY, known for its blockbuster diabetes and obesity therapeutics, has recently taken a massive strategic pivot into preventive medicine by announcing simultaneous acquisition agreements with three privately held vaccine developers — Curevo, LimmaTech Biologics and Vaccine Comp…
Pharma giant Eli Lily LLY, known for its blockbuster diabetes and obesity therapeutics, has recently taken a massive strategic pivot into preventive medicine by announcing simultaneous acquisition agreements with three privately held vaccine developers — Curevo, LimmaTech Biologics and Vaccine Comp…
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
